Phagocytic myeloid cells provide the principle line of immune defence during early embryogenesis in lower vertebrates. They may also have important functions during normal embryo morphogenesis, not least through the phagocytic clearance of cell corpses arising from apoptosis. We have identified two cDNAs that provide sensitive molecular markers of embryonic leukocytes in the early Xenopus embryo. These encode a peroxidase (XPOX2) and a Ly-6/uPAR-related protein (XLURP-1). We show that myeloid progenitors can first be detected at an antero-ventral site in early tailbud stage embryos (a region previously termed the anterior ventral blood island) and transiently express the haematopoetic transcription factors SCL and AML. Phagocytes migrate from this site along consistent routes and proliferate, becoming widely distributed throughout the tadpole long before the circulatory system is established. This migration can be followed in living embryos using a 5 kb portion of the XLURP-1 promoter to drive expression of EGFP specifically in the myeloid cells. Interestingly, whilst much of this migration occurs by movement of individual cells between embryonic germ layers, the rostral-most myeloid cells apparently migrate in an anterior direction along the ventral midline within the mesodermal layer itself. The transient presence of such cells as a strip bisecting the cardiac mesoderm immediately prior to heart tube formation suggests that embryonic myeloid cells may play a role in early cardiac morphogenesis. q
Introduction
The adaptive immune system appears relatively late during embryonic development of the anuran amphibian Xenopus laevis (Nagata, 1977; Tochinai, 1980) . By the time differentiated lymphocytes emerge to the periphery from the newly formed thymus (Kau and Turpen, 1983; Maeno et al., 1985) , the feeding tadpole is already 12 days old. Prior to this, the embryo must rely on the innate immune system of phagocytic myeloid blood cells (these are sometimes referred to as phagocytes, non-lymphoid leukocytes, or abbreviated to leukocytes). It is commonly held that myeloid cells can offer protection from at least 98% of all pathogens encountered (Jones, 2000) , and so their formation during early development may be fundamental to survival of lower vertebrate embryos growing in a hostile aquatic environment.
In addition to this role, myeloid cells are likely to have important functions during normal embryogenesis. In Drosophila embryos, phagocytic clearance of cell corpses resulting from apoptosis is primarily mediated by macrophages that originate from the embryonic haemocyte population (Franc et al., 1999; Tepass et al., 1994) . In a similar manner, macrophages actively induce apoptosis of endothelial cells in the pupillary membrane of the developing mammalian eye (Diez-Roux et al., 1999) . Such findings suggest that myeloid cells could play an important role facilitating embryo morphogenesis, through their ability to engulf apoptotic corpses (Savill and Fadok, 2000) . Unfortunately, such a possibility has proved difficult to explore since few molecular markers are available either to identify embryonic myeloid cells, or to trace their ontogeny.
The embryonic origin of myeloid blood cells in vertebrates is poorly characterised, but is probably distinct from that of other blood lineages. In zebrafish embryos, early macrophages are first visualised in the most rostrally located region of ventrolateral mesoderm, just anterior to the cardiac field (Herbomel et al., 1999 (Herbomel et al., , 2001 . In amphibians, a leukocyte-specific antibody has identified a widely dispersed population of non-lymphoid leukocytes in X. laevis tadpoles, prior to the onset of cardiovascular circulation (Ohinata et al., 1989) . Grafting experiments indicate that such cells arise from the head region of early tailbud embryos (Ohinata et al., 1990) , unlike erythroid and lymphoid blood cell lineages which originate from ventral mesoderm below the gut (Ciau-Uitz et al., 2000; Kau and Turpen, 1983; Maeno et al., 1985; Turpen and Knudson, 1982) . Their precise origins could not be traced directly since the antigenic determinants recognised by the antibody only appear at the tadpole stage.
Here we present studies that establish the embryonic origin of myeloid cells in the amphibian X. laevis. We have identified two cDNAs, a peroxidase family member (XPOX2) and Ly-6/uPAR-Related Protein (XLURP-1), that provide molecular markers for myeloid cells from the early tailbud stage in Xenopus embryos. Expression of these cDNAs is restricted to a small population of cells, first detected in the antero-ventral region of the early tailbud embryo. These cells appear to proliferate and distribute rapidly throughout the embryo along consistent routes, at least 20 h before the cardiovascular circulation of the tadpole is established. Their subsequent location and behaviour matches that of non-lymphoid leukocytes, previously identified in the tadpole by antibody staining. Interestingly, we find that the early myeloid cells migrate through the ventral-most portion of the prospective heart myocardial tissue during the onset of heart tube formation, and transiently co-express the haematopoietic transcription factors SCL and AML whilst they reside in the anterior ventral blood island (VBI). Finally, as a first step towards investigating the potential functions of these cells in living embryos, we describe a transgenic line of X. laevis whose myeloid cells can be observed directly, using a myeloidspecific gene promoter (XLURP-1) to drive expression of the green fluorescent protein (EGFP).
Results

Isolation of XPOX2 and XLURP-1 cDNAs
In a search for cDNAs expressed within the developing heart field of the tailbud embryo, we used a subtraction strategy to construct a heart field-enriched cDNA library. A combination of DNA sequencing and in situ hybridisation was used to identify candidate cDNAs. This screen identified a 1448 bp cDNA encoding the partial sequence of a peroxidase, Xenopus POX2 (GenBank AF364820). A search of the Xenopus EST database identified a closely related 2534 bp cDNA corresponding to a second XPOX2 (B) XLURP-1 sequence compared with other Ly-6/uPAR and snake venom toxin 'threefinger' proteins. To make the most appropriate comparison of these structurally related proteins, the positions of eight of the ten disulphide-forming cysteines (one, and four to ten) were manually aligned first. These four disulphides maintain the structure of the hydrophobic core from which protrude the three loops or fingers (Tsetlin, 1999) . The position of the disulphide formed between the second and third cysteines can vary within loop 1 of Ly-6/uPAR proteins and is absent from the snake venom toxins. The arginine located between the fifth and sixth cysteines interacts with the mature C-terminal asparagine and so was also aligned manually (Fleming et al., 1993) . Having made these constraints (indicated by asterisks above the sequences), the remaining regions of the sequences were aligned using the MegAlign program (DNASTAR Inc). GenBank accession numbers: Xenopus POX2, AF364820; Xenopus POX2 0 , AY069942; Xenopus allele (GenBank AY069942, IMAGE clone 4203899) that encoded the complete 725 amino acid polypeptide (Fig.  1A) . The existence of two POX2 transcripts in X. laevis most probably results from the pseudotetraploid character of this species (Bisbee et al., 1977) . XPOX2 0 resembles the one other Xenopus peroxidase family member characterised to date, the polysomal ribonuclease PMR-1 (Chernokalskaya et al., 1998) . XPOX2 0 protein is 66% identical to XPMR-1, shows 55% identity to the mammalian haematopoietic peroxidases, myeloperoxidase and eosinophil peroxidase, and 47% identity to a zebrafish myeloperoxidase polypeptide (Bennett et al., 2001) . The 456 bp cDNA encoding Xenopus LURP-1 (GenBank accession AF364819) encodes an 88 amino acid polypeptide (Fig. 1B) that belongs to the Ly-6/uPAR immune cell surface antigen and snake venom a-neurotoxin groups of 'three-finger' proteins (Fleming et al., 1993; Tsetlin, 1999) . While XLURP-1 is most closely related to the mouse Ly-6 protein ThB (36% amino acid identity), it lacks the cleavable GPI-anchor signal sequence (Wang et al., 1999) common to the extreme C-terminal region of Ly-6 proteins. We presume that the Xenopus protein is therefore secreted rather than tethered to the cytoplasmic membrane. A human secreted Ly-6/uPAR-related protein, SLURP-1, has previously been identified as a secreted rather than tethered polypeptide, but the weaker sequence similarity between XLURP-1 and human SLURP-1 (31% identity, and differing 'finger-lengths') suggests they are not orthologous genes (Andermann et al., 1999) . More likely, there are further secreted Ly-6 family members that await characterisation.
In addition to XPOX2 and XLURP-1, we have identified four novel Xenopus cDNAs that exhibit similarity to mammalian ADAM23, the CD34 1 stem cell protein HSPC280, a kallikrein 15-like elastase, and a pentraxinlike protein (data not shown, though GenBank accession numbers of mammalian homologs are AAD25099, AAF28958, NP_059979, P49263, respectively). Together, the cDNAs represent a family of markers expressed in the same cell population as XPOX2 and XLURP-1 (see Section 2.2).
Embryonic expression of XPOX2 and XLURP-1
XPOX2 mRNA expression is first detected by wholemount in situ hybridisation in the antero-ventral region of stage 19 embryos ( Fig. 2A, B) . Transverse sections of these embryos reveal that when first detected, the ventral XPOX2 expression domain is mesodermal (Fig. 3A, B) . By midtailbud stage, however, profound changes in the morphology and location of the XPOX2-expressing cells have occurred. Instead of residing together in the mesodermal layer, individual XPOX2-expressing cells are observed (Fig. 2C, D) . Moreover, XPOX2-expressing cells are now detected in the anterior-two-thirds and the ventral-half of stage 24 embryos (Fig. 2C, D) .
We analysed progressive transverse sections through mid-tailbud embryos after whole-mount in situ hybridisa- tion to characterise the precise distribution of cells expressing XPOX2. From the level of the cement gland to the trunk, punctate XPOX2-expressing cells reside between the ectodermal and mesodermal layers, and also between mesodermal and endodermal layers in the ventro-lateral portion of the embryo (Fig. 3C-G) . However, the ventralmost cells, particularly those near the heart-forming region, form part of the mesodermal layer itself (Fig. 3F) . Inspection of more-posterior sections also reveals XPOX2-expressing cells within the endoderm, close to the remnant of the blastocoel cavity (Fig. 3H) .
As the tailbud embryo develops, XPOX2-positive cells are detected in progressively larger numbers, distributed ever more widely throughout the embryo. By stage 27, a few expressing cells can be detected dorsally near the roof plate ( Fig. 3J ) and many are located in proximity to the posterior region of the VBI (Fig. 3I) . Interestingly, such cells reside on both ectodermal and endodermal sides of the erythropoietic mesoderm that constitutes the posterior VBI. The anterior pattern of XPOX2-cell distribution is especially noteworthy around stage 27 with a particular concentration on the ventral midline, located between the newly forming progenitors of heart myocardium ( Fig. 2E-G) . From this point, the punctate XPOX2-expressing cells are distributed along a characteristic pattern of radial lines or streams that extend towards the head (Fig. 2G) . From stage 30 onwards, the cells visualised by XPOX2 expression are distributed throughout the embryo (Fig. 2H) , with a high concentration observed surrounding the proctodeum at swimming tadpole stages (data not shown).
The expression of XLURP-1 (Fig. 2I , J) appears similar to XPOX2 with the important exception that XLURP-1 mRNA is detected by whole-mount in situ hybridisation only in the punctate, cell population from stage 24 onwards , which depicts a cell that expresses XLURP-1 located between mesodermal and endodermal layers that was fixed while it apparently phagocytosed cell material from the endoderm (L, black arrow). Additionally, this phagocyte formed such tight contacts with two mesodermal cells that they were prised away from the bulk of the mesoderm as the germ layers became separated during the sectioning procedure. All sections have been counterstained to reveal cell nuclei. Red boxes mark the location of detail images. Ect/Mes, expressing cells located between ectodermal and mesodermal germ layers; Mes/End, expressing cells located between mesodermal and endodermal layers; CG, cement gland; Bla, remnant of the blastocoel cavity; RP, roof plate; NT, neural tube; E, eye.
and not in the small anterior population of the early tailbud embryo.
Expression of XPOX2 is restricted to antero-ventral embryo explants
The dynamic distribution of XPOX2 and XLURP-1-expressing cells revealed by in situ hybridisation suggests active migration and proliferation of a small group of founder cells. However, it could also be explained by rapid de novo differentiation of XPOX2 and XLURP-1-expressing cells at dispersed sites throughout the embryo. To investigate this further, we bisected early tailbud (stage 21) embryos diagonally, yielding anterior-ventral fragments containing the first detectable XPOX2-expressing cells, and also the corresponding posterior-dorsal fragments ( Fig. 4A-C) . These embryo explants were cultured until stage 33, by which stage XPOX2/XLURP-1-cells are normally distributed throughout the entire embryo ( (Fig. 4D) . A further eight posterior-dorsal explants contained fewer than ten positive cells, all of which were located close to the posterior region of the forming VBI, suggesting that these were the product of inaccurate dissections.
These results support the view that the appearance of XPOX2-expressing cells in the dorsal half of Xenopus embryos from late tailbud stages onwards is due to cell migration from their anterior-ventral site of origin. This experiment does not exclude the possibility that posteriordorsal tissue of stage 21 embryos makes some contribution to the XPOX2-cell population observed at stage 33, but is incapable of doing so when cultured in isolation as a tissue explant. We therefore sought a more direct way to follow the location of XPOX2 and XLURP-1-expressing cells as development proceeds.
Cells expressing an XLURP-1-EGFP transgene are migratory
In order to visualise XPOX2 and XLURP-1-expressing cells, we screened Xenopus genomic DNA fragments derived from the two genes for their ability to drive expression of an EGFP transgene in a pattern similar to that of the endogenous mRNA transcripts. From this, we identified a 5 kb fragment of genomic DNA immediately upstream of the XLURP-1 gene that, when integrated into the frog genome, appears to recapitulate the entire expression pattern of its endogenous counterpart (Figs. 5 and 6). Using the EGFP reporter, fluorescent cells are first observed at stage 24 in an antero-ventral location ( (Chambers et al., 1994) in this experiment (E,F). Pigmented-wildtype embryos were used for this experiment. CG, cement gland; A, anterior; P, posterior. attach to, then release themselves from, the vascular endothelial walls (Fig. 5G-J) .
XPOX2 and XLURP-1 are co-expressed
The punctate appearance of XPOX2 and XLURP-1-expressing cells, along with their detection in progressively more of the embryo in the early tadpole is similar to that previously reported for myeloid blood cells, identified with antibodies recognising Xenopus tadpole leukocyte lineages (Miyanaga et al., 1998; Ohinata et al., 1989) . Since both transcripts can be detected much earlier than the leukocyte antigens, one or both of them could provide a marker to examine the ontogeny of embryonic myeloid cells. As shown earlier, expression of XLURP-1 appears similar to that of XPOX2 (Fig. 2I, J) , at least from stage 24 onwards. We therefore sought to establish if XPOX2 and XLURP-1 were indeed expressed in the same cells. White arrows (A-E) indicate the dorsal-most limit of the fluorescent cell dispersal, though it is not the same cell labelled at each stage. Oedemas are commonly found in animals raised by the Xenopus transgenesis procedure, and one develops as a swelling on the ventral surface of the first embryo (A-E). Nevertheless, the fluid drains from the oedema once the blood circulation is initiated, and this animal appears normal at stage 41 (G). The red box (G) gives the location of the high magnification images (H-J), which represent a time-series taken at 10 s intervals. The red arrows (H-J) follow the path of a spherical blood cell that resides within the peripheral circulation. This cell resists the blood flow, pausing three times as it forms transient contacts with the vascular endothelium. The output levels of the different colour channels have been adjusted individually while rendering these dark-field images (A-G) in Adobe Photoshop. This approach enables the silhouette of the embryo to be observed, while giving the EGFP fluorescence a false-blue colour. A, anterior; P, posterior.
Late tailbud stage embryos expressing the XLURP-1-EGFP transgene were photographed immediately before fixation and then assayed for XPOX2 expression by in situ hybridisation. Two such embryos are shown in Fig. 6 . In the first (Fig. 6A-D) , the number and location of the fluorescent cells matches the data for XPOX2-expressing cells precisely. In the second transgenic embryo, all the fluorescent cells also express XPOX2 (Fig. 6E-J) , but there are also a number of punctate, XPOX2-positive cells, especially within the antero-ventral region of the embryo, that do not express detectable EGFP (Fig. 6E-J) . These results demonstrate that XLURP-1-expressing cells also express XPOX2, and support the results of double whole-mount in situ hybridisation to detect XPOX2 and XLURP-1 expression in nontransgenic embryos (data not shown).
The observation of XPOX2-positive/EGFP-negative cells in the transgenic embryos may indicate that XLURP-1 is expressed only in a subset of the punctate, XPOX2-positive cells or it may reflect a limitation in the fidelity of expression of the transgene (see Section 3).
XPOX2/XLURP-1-expressing cells are myeloid
In other vertebrate species, the expression of L-plastin has been used to identify leukocyte populations in the embryo. Consequently, we compared the expression of a Xenopus homolog of L-plastin (IMAGE clone 4175686) with POX2, using a sequential, double whole-mount in situ hybridisation procedure. L-plastin mRNA can be detected only weakly in Xenopus tailbud embryos, with stronger expression observed by stage 35. Subsequent development of the XPOX2 probe demonstrated unequivocally that in stage 35 tadpoles, all cells expressing L-plastin also express POX2 (Fig. 2K, L) .
Further evidence that XPOX2/XLURP-1-expressing cells are indeed embryonic myeloid cells is provided by histological studies. The lower intensity of staining for XLURP-1 mRNA has made it possible to identify expressing cells that had been fixed as they phagocytosed adjacent tissue. For example, Fig. 3K (detail Fig. 3L ) shows a cell with XLURP-1 mRNA staining its cytoplasm blue. The cytoplasmic membrane of this cell, on the left (Fig. 3L, black arrow) , is apparently engulfing material from the endoderm. Furthermore, within the cytoplasm, a number of other phagosomelike vesicles are visible since they do not stain for XLURP-1 mRNA. Taken together, the distribution of XPOX2/XLURP-1-expressing cells in the tadpole, co-expression of L-plastin, their behaviour when observed in XLURP-1-EGFP transgenic embryos, and their apparent phagocytic activity, all indicate that these cells are indeed embryonic leukocytes.
Expression of XPOX2 within the heart field
The observation of myeloid cells within a region of the tailbud stage embryo previously thought to contain progenitors of the heart myocardium ( Fig. 3F) is intriguing, especially since their appearance coincides with the onset of heart tube formation. We therefore studied the relationship between myeloid cells and cardiac precursors in greater detail, by characterising the expression of XPOX2 using double whole-mount in situ hybridisation in combination with two markers of cardiogenesis, the tinman homolog, XNkx2-5, and a myosin light chain, XMLC1av. In early tailbud embryos, XPOX2 expression is first detected immediately posterior to the Nkx2-5 domain that encompasses cardiogenic mesoderm and the underlying pharyngeal endoderm (Fig. 7A) (Tonissen et al., 1994) . By stage 24, when individual myeloid cells can be observed, anterior XPOX2 expression is detected between bilateral Nkx2-5 domains (Fig. 7B, C) . We analysed progressive transverse sections through these mid-tailbud embryos at the level of the heart field. Significantly, at stage 24, XPOX2 expression in this region is observed in the ventral-most portion of the mesodermal layer and not in isolated migratory cells (Fig. 8A-C) .
This observation clarifies earlier reports on the expression of Nkx2-5 and other tinman homologs in Xenopus, whose mesodermal domains fuse in a narrow stripe across the ventral midline before stage 20 yet are detected as separate bilateral domains from stage 23 through to the onset of myocardial differentiation (Evans et al., 1995; Sparrow et al., 2000a; Tonissen et al., 1994) . Of course, we cannot exclude a model in which the ventral-most mesoderm that at first expresses Nkx2-5 loses its cardiogenic potential and differentiates into myeloid progenitors. Indeed the resolution of our data cannot discount weak Nkx2-5 expression in those cells that express XPOX2 within the heart field. Nevertheless, we believe it more likely that Nkx2-5-expressing cells are displaced from the ventral midline by mesoderm that is fated to produce leukocytes. That is, the rostral portion of myelopoietic mesoderm comes to occupy a ventral strip within the heart field as a result of the movement of these cells relative to the cardiogenic mesodermal cells. The timing of this remodelling coincides with the onset of developmental growth of the tailbud embryo along the antero-posterior axis (Larkin and Danilchik, 1999) .
At stage 26, the pattern of XPOX2 staining within the heart field has changed once more. Individual myeloid cells are now observed having migrated around the anterior limit of the lateral plate mesoderm between the heart field and the cement gland (Figs. 7D, E and 8D ). This results in streams of myeloid cells at the ventral edge of each Nkx2-5 domain that emanate from a focal point at the ventral midline, posterior to the cement gland (Fig. 7E) . Where the streams meet, transverse sections show that the cardiogenic mesoderm is split into two by the XPOX2 expression, which still resembles a cluster of cells rather than individual leukocytes (Fig. 8E) . The XPOX2-expressing cells caudal of the focal point more typically resemble migratory myeloid cells at this stage (Fig. 8F) .
Finally, we used XPOX2 expression to study the location of myeloid cells within developing hearts at swimming tadpole stages in combination with XMLC1av (GenBank AF364821). The mRNA of this cardiac myosin light chain is robustly expressed in all regions of the forming myocardium, including prospective atrial and ventricular chambers, with low level somitic expression also detected (S.J.S., unpublished data). After the onset of myocardial differentiation, fewer XPOX2-expressing cells are detected in the heart-forming region of the embryo (Fig. 7F ). Prior to heart tube formation, they are present primarily at the anterior and dorsolateral edges of the myocardial plate (Fig. 7F) . Additional XPOX2-expressing myeloid cells can be detected between the myocardial region and the endoderm (Fig. 8G) . At linear and looping heart tube stages, transverse sections reveal individual leukocytes associated with the ventral side of the outer surface of the endocardium, residing between the endocardium and myocardium (Fig. 8H-K) .
Transient expression of haematopoietic transcription factors by myeloid cells
The transcription factor SCL plays a critical role in Fig. 8 . Transverse sections through the heart-forming region of Xenopus embryos after double whole-mount in situ hybridisation for the two markers of cardiogenesis (in pale blue), Nkx2-5 (A-F) and MLC1av (G-K), in combination with POX2 (magenta). (A-C) Three representative sections marking progressively posterior slices through the same stage 24 embryo depicted in Fig. 7(B,C) . (D-F) Three progressively posterior sections through the stage 26 embryo depicted in Fig. 7(D,E) . Red arrows mark the ventral-most XPOX2-expressing mesodermal cells within the heart field. haematopoiesis and vasculogenesis (Barton et al., 1999) and in Xenopus, it is expressed in a broad antero-ventral, mesodermal domain of the early tailbud embryo (Mead et al., 1998) that would encompass the XPOX2-expressing myeloid progenitor cells. As development proceeds, expression of SCL becomes restricted to the VBI, posterior to the developing heart (Mead et al., 1998) . In order to establish the precise relationship between the myeloid progenitors and the other haematopoietic precursors in the tailbud embryo, we compared the expression of Xenopus POX2 with SCL, using sequential, double whole-mount in situ hybridisation.
In the early tailbud (stage 20), a major portion of the SCL expression domain co-expresses XPOX2 (Fig. 9A, E) . However, the two expression domains soon resolve from each other and by stage 22, XPOX2-positive myelopoietic mesoderm still occupies the ventral midline but the same cells express only low levels of SCL (Fig. 9B, F) . Strong SCL expression is now observed in cells immediately posterior of the myeloid progenitors and also in two anterior-bilateral domains that in part surround the myeloid progenitors. By stage 24, XPOX2 expression is restricted rostrally to a narrow midline strip (residing between bilateral Nkx2-5 domains) and caudally to a more dispersed group of cells. Moreover, repression of SCL expression has occurred in most of the region occupied by caudal myeloid cells (Fig.  9C, G) . The few XPOX2-positive, punctate cells that appear to retain SCL expression are most probably migratory leukocytes that reside between the embryonic germ layers (Fig.  9C, G) . By late tailbud stage, leukocytes that express XPOX2 are detected dispersed across the erythropoietic mesoderm of the posterior VBI (Fig. 9D, H) .
In summary, the myeloid progenitor cells transiently express the haematopoietic transcription factor SCL, and lie within a broader SCL expression domain that expands caudally as the tailbud embryo develops. The caudal portion of this comprises erythroid progenitor cells of the VBI that form below the gut endoderm, whilst the anterior, bilateral horns of SCL expression that flank the myeloid precursors (Fig. 9C, G) probably comprise vascular endothelial progenitors that will form the vitelline veins and perhaps the endocardium (Mead et al., 1998) . Qualitatively similar results were obtained with a second haematopoietic transcription factor, AML (CBFa2) (Tracey et al., 1998; Tracey and Speck, 2000) . AML expression detected by double whole-mount in situ hybridisation persists in myeloid progenitors until after stage 23, whereupon it is down-regulated in a similar fashion to SCL (data not shown).
Discussion
XPOX2 and XLURP-1 are myeloid cell markers
Embryonic myeloid cells are likely to play an important role in embryo morphogenesis, through their phagocytic clearance of cell corpses. They are thus key participants in the process of apoptotic cell death, regulated patterns of which occur during development of the embryo. However, to date the dearth of molecular markers has hindered studies of the origins and functions of these cells in vertebrates.
Several lines of evidence indicate that XPOX2 and XLURP-1 provide markers for embryonic myeloid cells in Xenopus. Cells expressing these mRNAs are distributed throughout the embryo in a pattern similar to that reported for non-lymphoid leukocytes (Miyanaga et al., 1998; Ohinata et al., 1989) . XPOX2 is initially expressed in an antero-ventral region of stage 19 embryos, consistent with earlier grafting experiments which suggested that myeloid cells originate rostral to the gill rudiments (Ohinata et al., 1990) . The morphology of the cells, after detection by XLURP-1 expression, suggests that they are phagocytes. Our tissue explant experiments suggest that XPOX2-expressing cells are migratory, and imply that the entire population of positive cells found in swimming tadpoles originates from the domain of early XPOX2 expression. Moreover, in transgenic animals, the promoter of the XLURP-1 gene specifically directs the expression of fluorescent reporter proteins to cells that are actually observed to migrate from their antero-ventral origin. These cells co-express XPOX2 mRNA and after their dispersal, they resemble both tissueresident macrophages, and other leukocytes circulating in the peripheral blood. Finally, the nature of XPOX2 and XLURP-1 gene products, along with those of five other cDNAs we have identified (including L-plastin) that exhibit the same pattern of expression, is suggestive of their being leukocyte or myeloid cell proteins.
Earlier studies of tadpole myeloid cells, identified by leukocyte-specific antibodies, suggested the presence of both mononuclear macrophage and polymorphonuclear granulocyte lineages on the basis of cellular morphology (Miyanaga et al., 1998; Ohinata et al., 1989) . In our Xenopus transgenesis experiments, we observed a subset of myeloid cells that expressed XPOX2, yet did not exhibit detectable XLURP-1 promoter activity (Fig. 6G-J) . We are investigating whether variability in the intensity of EGFP fluorescence among the myeloid cells of a single embryo could be an anomaly associated either with the transgenesis procedure or with the choice of XLURP-1 promoter fragment. Alternatively, it is possible that XPOX2-positive/XLURP-1-EGFP-negative cells constitute a distinct cell type among the myeloid population. As far as we know, the transgene recapitulates the entire expression pattern of the endogenous XLURP-1 gene with no evident ectopic activity. For example, like the endogenous gene, the transgene does not appear to be expressed in the rostral-most myeloid cells that remain as part of the mesodermal layer within the heart field.
Among the fluorescent cells of XLURP-1-EGFP embryos, we observed tissue macrophages but were not able to identify distinct leukocyte lineages for the fluorescent cells in the peripheral blood. The limited histological resolution available after whole-mount in situ hybridisation also prevented us from assigning these cell lineages. For these reasons, we have used the more general term, 'myeloid cell', until more is known of phagocyte populations in the embryo. Our study has only identified such cells up to swimming tadpole stages and we have not yet studied feeding tadpoles in which the thymic rudiment forms (Nagata, 1977; Tochinai, 1980) . We do not therefore know if markers we have identified remain specific for myeloid leukocytes in later stages of development or whether they will identify definitive lymphoid cells of the adult. Consequently, we are raising EGFP-expressing, XLURP-1 promoter transgenic tadpoles to adulthood in order to examine questions of leukocyte differentiation and function at later stages of vertebrate development.
Myeloid cells and the heart field
An intriguing feature of the expression pattern for XPOX2 is its spatial relationship with cells destined to form the heart. In early tailbud stage embryos, mesoderm fated to produce myeloid cells is located posterior to the cardiac field of Nkx2-5 expression, but as the tailbud embryo grows, the rostral extent of the myelopoietic cells comes to lie in a narrow, ventral, mesodermal domain within the heart field, Nkx2-5-expressing cardiogenic mesoderm apparently being displaced on either side. This arrangement coincides with the onset of morphogenetic changes that convert the myocardial mesoderm into a linear heart tube and is transitory, since the myeloid cells subsequently appear to migrate anteriorly towards the head, leaving few in the heart primordium.
It is noteworthy that the first evidence of the endocardium is a cluster of cells with a central lumen, dorsal to the myocardial plate (Mohun et al., 2000; Nieuwkoop and Faber, 1956) . Interestingly, this is precisely the same location that the myeloid cells occupy just a few hours earlier.
Whilst it is possible that such rostral XPOX2-expressing cells of the mid-tailbud stage embryo themselves subsequently form the endocardial tube, we favour a model in which cell movements account for the sequential appearance of first myeloid and then vascular endothelial/endocardial progenitors within the cardiac field (Fig. 10) . The anterior-bilateral horns of SCL expression observed in Fig. 9C would thus be the candidate cells of the endocardium and vitelline veins (Mead et al., 1998) . In this model, there could be an active role for myeloid cells in assisting heart tube formation by phagocytosing apoptotic cells or inducing localised changes to the extracellular matrix (Kolker et al., 2000) .
The initial site of myeloid differentiation in Xenopus apparently conflicts with evidence in zebrafish, where early macrophages arise from ventro-lateral mesoderm located rostral of the cardiac field (Herbomel et al., 1999) . This difference can perhaps be explained by considering the atrio-ventricular patterning evident during zebrafish cardiac development, which is also reversed at linear heart tube stages with respect to amphibians (Yelon et al., 1999) . Thus, in both lower vertebrate models, myeloid cell development occurs adjacent to the side of the cardiac field that will ultimately form the inflow tract and atrial chamber(s).
Myeloid cells and the VBI
In Xenopus, the first peripheral blood cells arise exclusively from the VBI of tailbud stage embryos, while progeny of the dorsolateral plate (DLP) contribute most cells to the circulation during late larval stages and in the adult frog (Kau and Turpen, 1983; Maeno et al., 1985) . Recently, the embryonic origin of the VBI has been determined and appears more complex than was first thought. In addition to a well-characterised domain that arises from progeny of the ventral blastomeres at the four-cell stage, studies of the haematopoietic transcription factors, AML, SCL, and GATA-2 have revealed an anterior domain that is derived from dorsal blastomeres of the early embryo (Ciau-Uitz et al., 2000; Tracey et al., 1998) .
Early studies demonstrated that in addition to supplying circulating erythrocytes, cells from the posterior compartment of the VBI invade the thymic rudiment between stages 43 and 47 (Nagata, 1977; Tochinai, 1980) , with differentiated lymphocytes emerging to the periphery some time after stage 49 (Kau and Turpen, 1983; Maeno et al., 1985) . More recently, lineage-labelling experiments have shown that progeny cells of dorsal blastomeres overlap with the a-globin expression domain, indicating that the anterior compartment of the VBI is also a source of erythroid cells (Tracey et al., 1998) . In the present study, we have identified XPOX2-expressing cells at stage 19 at an antero-ventral site that correlates with the location of the anterior VBI. Specifically, we have found that when first detected, XPOX2-positive myeloid progenitors also express SCL and AML. This co-expression is transient, with first SCL and then AML mRNA being repressed as myeloid differentiation proceeds. Moreover, in cell-fate mapping experiments, we have found that the myeloid progenitors detected in the early tailbud (stages 22-23) are entirely the progeny of the dorsal-vegetal blastomeres of the eightcell stage embryo (Fig. 11, see figure legend for experiment description). Together, these results indicate that a significant portion of the anterior VBI is in fact myelopoietic. Furthermore, our finding that such anterior-derived myeloid cells subsequently migrate over the surface of the ventrally derived posterior VBI indicates a hitherto unsuspected complexity in the interpretation of lineage-labelling experiments. As a result, it will be important to re-examine the extent to which the presence of dorsally derived cells in the a-globin expression domain actually results from migratory phagocytes rather than reflecting the contribution of the anterior VBI to embryonic erythropoiesis.
Experimental procedures
4.1. Isolation and sequencing of XPOX2 and XLURP-1 cDNA X. laevis POX2 and LURP-1 clones were isolated from a stage 22 cDNA library in pSPORT1 made from an anteriorventral tissue dissection that included the heart field and some adjacent cement gland tissue. cDNAs were sequenced using an Applied Biosystems 377 sequencer and analysed using the Lasergene suite of programs (DNASTAR Inc.).
Whole-mount in situ hybridisation
Albino, but also some pigmented-wildtype, embryos were fixed in MEMFA prior to RNA whole-mount in situ hybridisation using digoxigenin-labelled antisense probes (Harland et al., 1991; Sive et al., 2000) . Double-labelled in situ hybridisations used fluorescein-, and digoxigeninincorporated probes, and BCIP (without NBT) (Roche) and Magenta-Phos (Biosynth AG) were employed for the chromogenic reactions. A sequential procedure for double whole-mount in situ hybridisation was adopted, where embryos were photographed successively after the chromogenic reactions for each probe were developed. Antisense probes corresponded to the full-length cDNAs for XLURP- Fusion of the bilateral cardiogenic mesoderm on the ventral midline. These progenitors ultimately form the muscular myocardial tube, and also the non-muscle pericardial and mesocardial components of the heart. As a direct consequence of the myeloid cell dispersal, the region adjacent and posterior to the developing tadpole heart is devoid of mesoderm. This region accommodates the liver rudiment as it grows out from the gut endoderm. Finally, it should be noted that the origin of the endocardium is not certain. Alternative models are possible with the endocardium forming from the anterior, arterial pole of the heart (not shown in this model), or even resulting from differentiation of cells within the cardiac or myeloid domains. A, anterior; P, posterior; Mc.P, myocardial plate; Ec, endocardium.
1, XPOX2
0 , XMLC1av, XMLC2a (Chambers et al., 1994) and XNkx2-5 (Tonissen et al., 1994) . Shorter XPOX2-allele probes (nucleotides 1-1448, 390-1448, and also 1099-1448 of the XPOX2 allele sequence) were also used and gave identical results. Full-length cDNAs were used for XSCL (Mead et al., 1998) and XAML (Tracey et al., 1998) , and were kindly supplied by Roger Patient. For histological analysis, 10 mm sections were cut from fixed embryos embedded in Paraplast wax (BDH). The normal table of X. laevis (Nieuwkoop and Faber, 1956 ) was used to assess the developmental stage of embryos.
Tissue explant culture
Microsurgical dissections were performed on a bed of 1% agarose in 0.75 £ Normal Amphibian Medium (NAM) (Sive et al., 2000) , and resulting tissue explants were cultured at 188C in 0.75 £ NAM with 40 mg/ml gentamicin sulphate until they were fixed in MEMFA.
Cell-fate mapping
Approximately 3 nl of 1.25 mg/ml biotin-dextran 10,000 MW (Molecular Probes) was microinjected into individual blastomeres of Xenopus eight-cell stage embryos, in 4% ficoll 400,000, 0.75 £ NAM. Using the eight-cell stage for injection, as opposed to four-cell stage, gives more restricted targeting of the mesodermal germ layer. Only regularly cleaving embryos were chosen for injection. Embryos were allowed to develop in 0.1 £ NAM with gentamicin sulphate until fixing. Alkaline phosphataseconjugated ExtrAvidin (Sigma) and BCIP (without NBT) were employed for the chromogenic reaction.
Isolation of the XLURP-1 promoter
A X. laevis genomic DNA library in lFIX2 (Stratagene) was screened using a 407 bp hybridisation probe corresponding to a Sal1-Dra1, LURP-1 5 0 -cDNA fragment.
The resulting Not1 digested genomic DNA fragments of The XLURP-1 promoter fragment was cloned upstream of the EGFP coding sequence using two derivatives of pEGFP-1 (Clontech). pEGFP-1-8NPA contains a Not1-Pac1-Asc1 linker between the Pst1 and BamH1 sites, and allowed purification of an Asc1-Not1 EGFP fragment. pEGFP-1-8PmN contains a Pme1-Not1 linker between the same Pst1 and BamH1 sites, and allowed purification of an 'empty' Not1-vector fragment. The final expression construct, pLURP1-g03-EGFP, was made using the Not1-Asc1 XLURP-1 promoter fragment, the Asc1-Not1 EGFP fragment, and the Not1 digested 'empty' vector fragment of pEGFP-8PmN. The orientation of the cloned fragments was such that the EGFP translation stop codon was adjacent to the SV40 polyadenylation signal of the pEGFP-1-8PmN vector.
Xenopus transgenesis procedure
Transgenic Xenopus embryos were generated as described previously (Kroll and Amaya, 1996; Sparrow et al., 2000b) , except that pLURP1-g03-EGFP was simply linearised with Pme1, rather than separating the promoterreporter sequence from the plasmid vector. The transgenesis procedure has been repeated on five separate occasions, with different batches of eggs giving identical results. EGFP-detection of the full complement of myeloid cells, as opposed to a small sub-population of fluorescent leukocytes, occurred in approximately 40% of the transgenic embryos. Successful transgenesis depends upon uniform propagation of the integrated transgene from fertilised egg to all daughter cells of the embryo. EGFP fluorescence was detected using a Leica MZFLIII microscope equipped with a GFP2 emission filter. Fluorescent images were captured using a CoolSNAP camera and software from RS Photometrics.
